Genprex

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company product is REQORSA immunogen therapy drug for non-small cell lung cancer.

CEO

Ryan M. Confer

CEORyan M. Confer

Employees

Employees15

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2009

Founded2009

Employees

Employees15

GNPX Key Statistics

Market cap

7.12M

Market cap7.12M

Price-Earnings ratio

-0.08

Price-Earnings ratio-0.08

Dividend yield

—

Dividend yield—

Average volume

2.90M

Average volume2.90M

High today

$14.00

High today$14.00

Low today

$6.62

Low today$6.62

Open price

$9.52

Open price$9.52

Volume

4.26M

Volume4.26M

52 Week high

$149.50

52 Week high$149.50

52 Week low

$6.62

52 Week low$6.62

GNPX News

TipRanks 3h

Genprex announces registered direct offering of up to $10M

Genprex (GNPX) announced that it has entered into definitive agreements for the issuance and sale of 377,780 shares of common stock at a purchase price of $9.00...

TipRanks 20h

Genprex’s Innovative ES-SCLC Therapy: A Promising Clinical Update

Genprex ((GNPX)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock p...

TipRanks 5d

Genprex Announces Positive Preclinical Data on Reqorsa

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own GNPX. This list is generated using Robinhood data, and it’s not a recommendation.

Opendoor Technologies